A panelist discusses the evolving role of prophylactic tocilizumab in reducing cytokine release syndrome during bispecific antibody therapy, enabling outpatient treatment and improving patient ...
Enhanced antitumor activity of erlotinib in combination with quinacrine in EGFR WT and L858R/T790M mutant NSCLC. Functional comparison between genomic subtypes and protein signal transduction networks ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈